Skip to main content

Cytoxan News

Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia

MONDAY, June 24, 2024 – For patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation, posttransplant cyclophosphamide (PTCy) graft-versus-host-disease (GVHD)...

Strategy with Cyclophosphamide Could Expand Stem Cell Donor Pool for People Battling Blood Cancers

TUESDAY, May 28, 2024 – An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds....

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Chronic Lymphocytic Leukemia (CLL), Chronic Myelogenous Leukemia (CML), Diffuse Large B-Cell Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer

Cytoxan patient information at Drugs.com